{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:18:02Z","timestamp":1791328682065,"version":"4.3.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.beem.2004.08.005","type":"journal-article","created":{"date-parts":[[2004,11,9]],"date-time":"2004-11-09T11:54:21Z","timestamp":1100001261000},"page":"607-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders"],"prefix":"10.1016","volume":"18","author":[{"given":"Malcolm J.","family":"Low","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2004.08.005_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.179.4068.77","article-title":"Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone","volume":"179","author":"Brazeau","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.beem.2004.08.005_bib2","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1073\/pnas.77.10.5869","article-title":"Nucleotide sequence of a cloned structural gene coding for a precursor of pancreatic somatostatin","volume":"77","author":"Goodman","year":"1980","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.beem.2004.08.005_bib3","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJM198312153092406","volume":"309","author":"Reichlin S. Somatostatin","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2004.08.005_bib4","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJM198312223092506","volume":"309","author":"Reichlin S. Somatostatin (second of two parts)","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2004.08.005_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1023369317275","article-title":"Current status and future opportunities for controlling acromegaly","volume":"5","author":"Melmed","year":"2002","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2004.08.005_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1568007043482534","article-title":"Delineating somatostatin's neuronal actions","volume":"3","author":"Blake","year":"2004","journal-title":"Current Drug Targets in Central Nervous System and Neurological Disorders"},{"key":"10.1016\/j.beem.2004.08.005_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0306-4522(03)00560-8","article-title":"The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer's disease","volume":"122","author":"Winsky-Sommerer","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.beem.2004.08.005_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0165-0173(00)00031-X","article-title":"Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions","volume":"33","author":"Spier","year":"2000","journal-title":"Brain Research Reviews"},{"key":"10.1016\/j.beem.2004.08.005_bib9","series-title":"Encyclopedia of Hormones","first-page":"379","author":"Low MJ. Somatostatin","year":"2003"},{"key":"10.1016\/j.beem.2004.08.005_bib10","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1210\/jc.2003-030063","article-title":"Effect of ingested nutrients on the release of thrittene into the human circulation","volume":"88","author":"Ensinck","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2004.08.005_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1097-0029(20000301)48:5<272::AID-JEMT4>3.0.CO;2-N","article-title":"Developmental biology of gastrin and somatostatin cells in the antropyloric mucosa of the stomach","volume":"48","author":"Larsson","year":"2000","journal-title":"Microscopy Research Techniques"},{"key":"10.1016\/j.beem.2004.08.005_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-5793(99)00144-1","article-title":"Pax6 and Pdx1 form a functional complex on the rat somatostatin gene upstream enhancer","volume":"445","author":"Andersen","year":"1999","journal-title":"Federation of European Biochemical Society Letters"},{"key":"10.1016\/j.beem.2004.08.005_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/labinvest.3700074","article-title":"Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes","volume":"84","author":"Oh","year":"2004","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.beem.2004.08.005_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family","volume":"20","author":"Patel","year":"1999","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1016\/j.beem.2004.08.005_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(03)00235-9","article-title":"Somatotatin receptors","volume":"1616","author":"Moller","year":"2003","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.beem.2004.08.005_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nrd1255","article-title":"Opportunities in somatostatin research: biological, chemical and therapeutic aspects","volume":"2","author":"Weckbecker","year":"2003","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.beem.2004.08.005_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1210\/me.2001-0035","article-title":"Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis","volume":"17","author":"Strowski","year":"2003","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.beem.2004.08.005_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/endo.141.1.7263","article-title":"Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice","volume":"141","author":"Strowski","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2004.08.005_bib19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.288.5463.154","article-title":"Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity","volume":"288","author":"Rocheville","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.beem.2004.08.005_bib20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3109\/00365528708991938","article-title":"Circulating immunoreactive somatostatin in gastrointestinal diseases. Decrease after vagotomy and enhancement in active ulcerative colitis, irritable bowel syndrome, and duodenal ulcer","volume":"22","author":"Binimelis","year":"1987","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.beem.2004.08.005_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1469-7793.2000.00497.x","article-title":"Patch-clamp characterisation of somatostatin-secreting-cells in intact mouse pancreatic islets","volume":"528","author":"Gopel","year":"2000","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.beem.2004.08.005_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.103.053512","article-title":"Neurotransmitters mediating the intestinal peristaltic reflex in the mouse","volume":"307","author":"Grider","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.beem.2004.08.005_bib23","doi-asserted-by":"crossref","first-page":"G624","DOI":"10.1152\/ajpgi.00354.2001","article-title":"Somatostatin sst(2) receptors inhibit peristalsis in the rat and mouse jejunum","volume":"282","author":"Abdu","year":"2002","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.beem.2004.08.005_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2982.2003.00400.x","article-title":"Effects of Schistosoma mansoni infection on somatostatin and somatostatin receptor 2A expression in mouse ileum","volume":"15","author":"De Jonge","year":"2003","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.beem.2004.08.005_bib25","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1097\/00006676-200311000-00019","article-title":"Activation of somatostatin receptor subtype 2 inhibits insulin secretion in the isolated perfused human pancreas","volume":"27","author":"Brunicardi","year":"2003","journal-title":"Pancreas"},{"key":"10.1016\/j.beem.2004.08.005_bib26","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1023\/A:1012392307462","article-title":"Somatostatin enhances cAMP-dependent short-circuit current in human colon via somatostatin receptor subtype-2","volume":"46","author":"Hope","year":"2001","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.beem.2004.08.005_bib27","doi-asserted-by":"crossref","first-page":"E311","DOI":"10.1152\/ajpendo.00434.2001","article-title":"Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures","volume":"283","author":"Chisholm","year":"2002","journal-title":"Amercian Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2004.08.005_bib28","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1152\/japplphysiol.00281.2002","article-title":"A model for integrative study of human gastric acid secretion","volume":"94","author":"Joseph","year":"2003","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.beem.2004.08.005_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(02)02309-9","article-title":"Antisecretory effect of somatostatin on gastric acid via inhibition of histamine release in isolated mouse stomach","volume":"452","author":"Komasaka","year":"2002","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.beem.2004.08.005_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1097-0029(20000301)48:5<241::AID-JEMT2>3.0.CO;2-2","article-title":"Innervation of the gastric mucosa","volume":"48","author":"Ekblad","year":"2000","journal-title":"Microscopy Research Techniques"},{"key":"10.1016\/j.beem.2004.08.005_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/003655101317095428","article-title":"Control of secretion from rat stomach ECL cells in situ and in primary culture","volume":"234","author":"Hakanson","year":"2001","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation\/Supplement"},{"issue":"supplement 2","key":"10.1016\/j.beem.2004.08.005_bib32","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/annonc\/12.suppl_2.S19","article-title":"Nerve-driven immunity: neuropeptides regulate cytokine secretion of T cells and intestinal epithelial cells in a direct, powerful and contextual manner","volume":"12","author":"Levite","year":"2001","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.beem.2004.08.005_bib33","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.4049\/jimmunol.165.6.2955","article-title":"Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells","volume":"165","author":"Chowers","year":"2000","journal-title":"Journal of Immunology"},{"issue":"supplement 2","key":"10.1016\/j.beem.2004.08.005_bib34","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1093\/annonc\/12.suppl_2.S95","article-title":"Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours","volume":"12","author":"Tomassetti","year":"2001","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.beem.2004.08.005_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0039-6109(05)70141-9","article-title":"Islet cell tumors of the pancreas: the medical oncologist's perspective","volume":"81","author":"Brentjens","year":"2001","journal-title":"Surgical Clinics of North America"},{"key":"10.1016\/j.beem.2004.08.005_bib36","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1210\/jcem.86.8.7787","article-title":"Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment","volume":"86","author":"Ballare","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2004.08.005_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/gast.2001.21192","article-title":"Transcription of SST2 somatostatin receptor gene in human pancreatic cancer cells is altered by single nucleotide promoter polymorphism","volume":"120","author":"Torrisani","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2004.08.005_bib38","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI11941","article-title":"Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth","volume":"107","author":"Low","year":"2001","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.beem.2004.08.005_bib39","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0016-5085(98)70417-2","article-title":"High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice","volume":"114","author":"Martinez","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2004.08.005_bib40","doi-asserted-by":"crossref","first-page":"12944","DOI":"10.1073\/pnas.2135193100","article-title":"Treatment of Helicobacter gastritis with IL-4 requires somatostatin","volume":"100","author":"Zavros","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.beem.2004.08.005_bib41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1523-5378.2001.00020.x","article-title":"Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients","volume":"6","author":"Yamamoto","year":"2001","journal-title":"Helicobacter"},{"key":"10.1016\/j.beem.2004.08.005_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1440-1746.2003.03008.x","article-title":"Enhanced somatostatin secretion into the gastric juice with recovery of basal acid output after Helicobacter pylori eradication in gastric ulcers","volume":"18","author":"Hayakawa","year":"2003","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.beem.2004.08.005_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jtbi.2003.12.004","article-title":"A model for the study of Helicobacter pylori interaction with human gastric acid secretion","volume":"228","author":"Joseph","year":"2004","journal-title":"Journal of Theoretical Biology"},{"key":"10.1016\/j.beem.2004.08.005_bib44","first-page":"755","article-title":"Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six-month, follow-up study","volume":"15","author":"Milutinovic","year":"2003","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.beem.2004.08.005_bib45","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1021\/jm021093t","article-title":"A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential","volume":"46","author":"Lewis","year":"2003","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.beem.2004.08.005_bib46","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.282.5389.737","article-title":"Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry","volume":"282","author":"Rohrer","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.beem.2004.08.005_bib47","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.95.18.10836","article-title":"Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2","volume":"95","author":"Yang","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.beem.2004.08.005_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-002-0656-5","article-title":"Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806","volume":"367","author":"Nunn","year":"2003","journal-title":"Naunyn Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.beem.2004.08.005_bib49","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1021\/jm0108449","article-title":"Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity","volume":"44","author":"Poitout","year":"2001","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.beem.2004.08.005_bib50","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","article-title":"Octreotide","volume":"334","author":"Lamberts","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2004.08.005_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/erc.0.0110001","article-title":"Neuroendocrine tumours","volume":"11","author":"Barakat","year":"2004","journal-title":"Endocrine Related Cancer"},{"key":"10.1016\/j.beem.2004.08.005_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1677\/erc.0.0110019","article-title":"Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract and pancreas","volume":"11","author":"de Herder","year":"2004","journal-title":"Endocrine Related Cancer"},{"key":"10.1016\/j.beem.2004.08.005_bib53","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1200\/JCO.2003.12.142","volume":"21","author":"Faiss","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beem.2004.08.005_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1385\/ENDO:20:3:285","article-title":"Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors","volume":"20","author":"de Herder","year":"2003","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2004.08.005_bib55","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1155\/2003\/645751","article-title":"Octreotide for enterocutaneous fistulas of Crohn's disease","volume":"17","author":"Lavy","year":"2003","journal-title":"Canadian Journal of Gastroenterology"},{"key":"10.1016\/j.beem.2004.08.005_bib56","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0889-8553(03)00099-2","article-title":"Portal hypertensive bleeding","volume":"32","author":"Comar","year":"2003","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1016\/j.beem.2004.08.005_bib57","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1572-0241.1999.929_b.x","article-title":"The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man","volume":"94","author":"Kubba","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.beem.2004.08.005_bib58","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2036.2003.01657.x","article-title":"Pharmacological rationale for the use of somatostatin and analogues in portal hypertension","volume":"18","author":"Reynaert","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.beem.2004.08.005_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clpt.2003.09.006","article-title":"Lanreotide effect on splanchnic blood flow in healthy subjects: effect of the rate of infusion","volume":"75","author":"Sieber","year":"2004","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.beem.2004.08.005_bib60","first-page":"PI84","article-title":"Somatostatin infusion and hemodynamic changes in patients with non-variceal upper gastrointestinal bleeding: a pilot study","volume":"9","author":"Saruc","year":"2003","journal-title":"Medical Science Monitor"},{"key":"10.1016\/j.beem.2004.08.005_bib61","first-page":"183","article-title":"Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber-bleb nevus syndrome","volume":"33","author":"Gonzalez","year":"2001","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1016\/j.beem.2004.08.005_bib62","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1590-8658(01)80087-6","article-title":"Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract","volume":"33","author":"Orsi","year":"2001","journal-title":"Digestive and Liver Disorders"},{"key":"10.1016\/j.beem.2004.08.005_bib63","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/gut.52.12.1768","article-title":"Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial","volume":"52","author":"Poon","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.beem.2004.08.005_bib64","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1746.2003.03297.x","article-title":"Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial","volume":"19","author":"Arvanitidis","year":"2004","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.beem.2004.08.005_bib65","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1046\/j.1440-1746.2003.02850.x","article-title":"Chylous ascites caused by portal vein thrombosis treated with octreotide","volume":"18","author":"Leong","year":"2003","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.beem.2004.08.005_bib66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.peptides.2003.11.017","article-title":"Octreotide ameliorates alendronate-induced gastric injury","volume":"25","author":"Sener","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.beem.2004.08.005_bib67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.33549\/physiolres.930488","article-title":"Somatostatin: beneficial effects on remission in young adult patients with newly diagnosed diabetes mellitus type 1","volume":"53","author":"Vondra","year":"2004","journal-title":"Physiology Research"},{"key":"10.1016\/j.beem.2004.08.005_bib68","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1517\/13543784.12.9.1501","article-title":"The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes","volume":"12","author":"Boehm","year":"2003","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.beem.2004.08.005_bib69","first-page":"493","article-title":"Use of somatostatin receptor ligands in obesity and diabetic complications","volume":"16","author":"Boehm","year":"2002","journal-title":"Best Practice and Reseach. Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2004.08.005_bib70","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000126831","article-title":"Effects of somatostatin on human satiety","volume":"61","author":"Lieverse","year":"1995","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2004.08.005_bib71","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0196-9781(98)00053-9","article-title":"Somatostatin administration modifies food intake, body weight, and gut motility in rat","volume":"19","author":"Scalera","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.beem.2004.08.005_bib72","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1210\/jc.2003-030205","article-title":"Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome","volume":"88","author":"Haqq","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2004.08.005_bib73","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0006-291X(03)00178-5","article-title":"Somatostatin suppresses ghrelin secretion from the rat stomach","volume":"302","author":"Shimada","year":"2003","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.beem.2004.08.005_bib74","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2265.2002.01649.x","article-title":"Ghrelin immunoreactivity in human plasma is suppressed by somatostatin","volume":"57","author":"Norrelund","year":"2002","journal-title":"Clinical Endocrinology (Oxford)"},{"issue":"supplement 1","key":"10.1016\/j.beem.2004.08.005_bib75","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000201413","article-title":"The place of octreotide in the medical management of the dumping syndrome","volume":"57","author":"Scarpignato","year":"1996","journal-title":"Digestion"},{"issue":"supplement 1","key":"10.1016\/j.beem.2004.08.005_bib76","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.dld.2003.11.024","article-title":"Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours","volume":"36","author":"Gibril","year":"2004","journal-title":"Digestive and Liver Disorders"},{"key":"10.1016\/j.beem.2004.08.005_bib77","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/snuc.2002.31022","article-title":"Somatostatin receptor imaging","volume":"32","author":"Kwekkeboom","year":"2002","journal-title":"Seminars in Nuclear Medicine"},{"key":"10.1016\/j.beem.2004.08.005_bib78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2168.2001.01644.x","article-title":"Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours","volume":"88","author":"Slooter","year":"2001","journal-title":"British Journal of Surgery"},{"key":"10.1016\/j.beem.2004.08.005_bib79","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/rheumatology\/keg479","article-title":"Expression of somatostatin receptors in inflammatory lesions and diagnostic value of somatostatin receptor scintigraphy in patients with ANCA-associated small vessel vasculitis","volume":"43","author":"Neumann","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.beem.2004.08.005_bib80","first-page":"270","article-title":"The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis","volume":"47","author":"Dalm","year":"2003","journal-title":"Quarterly Journal of Nuclear Medicine"},{"key":"10.1016\/j.beem.2004.08.005_bib81","article-title":"Diagnosis and staging of children's lymphoma using the technetium-labelled somatostatin analogue Tc-depreotide","author":"Cholewinski","year":"2004","journal-title":"European Journal of Nuclear Medicine and Molecular"},{"key":"10.1016\/j.beem.2004.08.005_bib82","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000074519","article-title":"Influence of somatostatin receptor scintigraphy and CT\/MRI on the clinical management of patients with gastrointestinal neuroendocrine tumors: an analysis in 188 patients","volume":"68","author":"Gotthardt","year":"2003","journal-title":"Digestion"},{"key":"10.1016\/j.beem.2004.08.005_bib83","first-page":"1053","article-title":"PET imaging of somatostatin receptors using [68Ga] DOTATOC","volume":"42","author":"Henze","year":"2001","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.beem.2004.08.005_bib84","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00001813-200309000-00002","article-title":"TT-232: a somatostatin structural derivative as a potent antitumor drug candidate","volume":"14","author":"Szende","year":"2003","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.beem.2004.08.005_bib85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pharmthera.2004.02.002","article-title":"Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis","volume":"102","author":"Dasgupta","year":"2004","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.beem.2004.08.005_bib86","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/annonc\/mdf142","article-title":"The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?","volume":"13","author":"Hejna","year":"2002","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.beem.2004.08.005_bib87","first-page":"1197","article-title":"Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo","volume":"16","author":"Raderer","year":"2000","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.beem.2004.08.005_bib88","doi-asserted-by":"crossref","first-page":"39356","DOI":"10.1074\/jbc.M304524200","article-title":"sst2 somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation","volume":"278","author":"Lahlou","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2004.08.005_bib89","first-page":"211","article-title":"Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial","volume":"2","author":"Pan","year":"2003","journal-title":"Hepatobiliary and Pancreatic Diseases International"},{"key":"10.1016\/j.beem.2004.08.005_bib90","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.cad.0000127330.21686.26","article-title":"Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-I: hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinoma","volume":"15","author":"Reidy","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.beem.2004.08.005_bib91","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11938-003-0048-z","article-title":"Treatment of hepatocellular carcinoma","volume":"6","author":"Schwartz","year":"2003","journal-title":"Current Treatment Options in Gastroenterology"},{"key":"10.1016\/j.beem.2004.08.005_bib92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00001622-200201000-00010","article-title":"Somatostatin and somatostatin analogues: diagnostic and therapeutic uses","volume":"14","author":"de Herder","year":"2002","journal-title":"Current Opinion in Oncology"},{"key":"10.1016\/j.beem.2004.08.005_bib93","first-page":"21","article-title":"Perspectives of new potential therapeutic applications of somatostatin analogs","volume":"24","author":"Pawlikowski","year":"2003","journal-title":"Neuroendocrinology Letters"},{"key":"10.1016\/j.beem.2004.08.005_bib94","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1677\/erc.0.0100497","article-title":"Targeted radionuclide therapy for neuroendocrine tumours","volume":"10","author":"Lewington","year":"2003","journal-title":"Endocrine Related Cancer"},{"key":"10.1016\/j.beem.2004.08.005_bib95","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/beem.2001.0137","article-title":"Isotopic evaluation and therapy in patients with malignant endocrine disease","volume":"15","author":"Lewington","year":"2001","journal-title":"Best Practice and Research. Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2004.08.005_bib96","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/snuc.2002.31565","article-title":"In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial","volume":"32","author":"Virgolini","year":"2002","journal-title":"Seminars in Nuclear Medicine"},{"key":"10.1016\/j.beem.2004.08.005_bib97","first-page":"1556","article-title":"Evaluating the clinical effectiveness of 90Y-SMT 487 in patients with neuroendocrine tumors","volume":"44","author":"Bushnell","year":"2003","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.beem.2004.08.005_bib98","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-4804(03)00276-2","article-title":"Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts","volume":"115","author":"Celinski","year":"2003","journal-title":"Journal of Surgical Research"},{"key":"10.1016\/j.beem.2004.08.005_bib99","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1089\/10430349950018391","article-title":"Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer","volume":"10","author":"Rochaix","year":"1999","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.beem.2004.08.005_bib100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.semnuclmed.2003.09.005","article-title":"Imaging and therapy of tumors induced to express somatostatin receptor by gene transfer using radiolabeled peptides and single chain antibody constructs","volume":"34","author":"Buchsbaum","year":"2004","journal-title":"Seminars in Nuclear Medicine"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X04000569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X04000569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:37:31Z","timestamp":1761496651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X04000569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S1521690X04000569"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2004.08.005","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2004.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}